awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38122437-670B92D2-CCD2-4102-809A-E172795EDBFD
Q38122437-670B92D2-CCD2-4102-809A-E172795EDBFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38122437-670B92D2-CCD2-4102-809A-E172795EDBFD
Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.
P2860
Q38122437-670B92D2-CCD2-4102-809A-E172795EDBFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38122437-670B92D2-CCD2-4102-809A-E172795EDBFD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ed11760abced0383cb9e4e92fb0d0402035b0a3
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).